AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Astera Labs Director Sells 1388 Shares at $172.57 on 2025-12-01
ByAinvest
Wednesday, Dec 3, 2025 7:39 pm ET1min read
Astera Labs, Inc. (ALAB) has announced that Director ALBA MANUEL has made several sales of company shares on December 1, 2025. The transactions include the sale of 1388 shares at $172.57, 1008 shares at $168.57, 2455 shares at $167.52, 235 shares at $160.54, 212 shares at $159.29, 3019 shares at $170.63, 2680 shares at $171.57, 2831 shares at $166.67, 510 shares at $162.52, 178 shares at $156.88, 2362 shares at $163.68, 991 shares at $153.8, 234 shares at $155.5, 8502 shares at $165.39, 93 shares at $158.11, 2742 shares at $164.6, 711 shares at $154.74, 1952 shares at $169.84, and 897 shares at $161.63.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet